Neuroone Medical Technologies Corp Net Assets
Neuroone Medical Technologies Corp net assets. Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has net assets worth $5.37 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.86 Million) and total liabilities ($2.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Neuroone Medical Technologies Corp equity growth rate to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.37 Million |
| % of Total Assets | 68.32% |
| Annual Growth Rate | N/A |
| 5-Year Change | 7.91% |
| 10-Year Change | N/A |
| Growth Volatility | 307.72 |
Net Assets of Neuroone Medical Technologies Corp (2010–2025)
Net assets of Neuroone Medical Technologies Corp from 2010 to 2025. This chart illustrates how Neuroone Medical Technologies Corp's net assets have evolved over time, based on quarterly financial data. See Neuroone Medical Technologies Corp balance sheet quality to measure how much of total assets are equity-financed.
Annual Net Assets for Neuroone Medical Technologies Corp (2010–2025)
The table below shows the annual net assets of Neuroone Medical Technologies Corp from 2010 to 2025. For live market cap and overall valuation, see Neuroone Medical Technologies Corp market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $7.07 Million | +760.39% |
| 2024-09-30 | $822.01K | -86.85% |
| 2023-09-30 | $6.25 Million | -34.93% |
| 2022-09-30 | $9.60 Million | +46.54% |
| 2021-09-30 | $6.55 Million | +217.20% |
| 2020-09-30 | $2.07 Million | +266.95% |
| 2019-09-30 | $-1.24 Million | +71.85% |
| 2018-09-30 | $-4.40 Million | -1551.23% |
| 2017-09-30 | $-266.22K | -226.68% |
| 2016-09-30 | $-81.49K | -130.27% |
| 2015-09-30 | $-35.39K | -25.06% |
| 2014-09-30 | $-28.30K | -64.17% |
| 2013-09-30 | $-17.24K | 0.00% |
| 2012-09-30 | $-17.24K | -426.00% |
| 2011-09-30 | $-3.28K | +24.20% |
| 2010-09-30 | $-4.32K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Neuroone Medical Technologies Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7860096400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Neuroone Medical Technologies Corp Net Assets Breakdown (September 2025)
Neuroone Medical Technologies Corp net assets breakdown by equity component as of September 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $50.01K | 0.71% |
| Other Components | $85.63 Million | 1210.77% |
| Total Equity | $7.07 Million | 100.00% |
Neuroone Medical Technologies Corp Competitors by Market Cap
The table below lists competitors of Neuroone Medical Technologies Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kamdar Group (Malaysia) Bhd
KLSE:8672
|
$8.45 Million |
|
Peako Ltd
AU:PKO
|
$8.45 Million |
|
Polar Capital Holdings plc
LSE:POLR
|
$8.45 Million |
|
Mobotix AG
F:MBQ
|
$8.46 Million |
|
Vitura Health Ltd
AU:VIT
|
$8.44 Million |
|
Zaklady Urzadzen Kotlowych Staporkow SA
WAR:ZUK
|
$8.43 Million |
|
Lima Dua Lima Tiga PT
JK:LUCY
|
$8.43 Million |
|
American Manganese Inc
V:AMY
|
$8.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Neuroone Medical Technologies Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 822,013 to 7,072,522, a change of 6,250,509 (760.4%).
- Net loss of 3,605,374 reduced equity.
- Share repurchases of 124,617 reduced equity.
- New share issuances of 9,614,037 increased equity.
- Other factors increased equity by 366,463.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.61 Million | -50.98% |
| Share Repurchases | $124.62K | -1.76% |
| Share Issuances | $9.61 Million | +135.94% |
| Other Changes | $366.46K | +5.18% |
| Total Change | $- | 760.39% |
Book Value vs Market Value Analysis
This analysis compares Neuroone Medical Technologies Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.93x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-09-30 | $-0.02 | $0.98 | x |
| 2011-09-30 | $-0.01 | $0.98 | x |
| 2012-09-30 | $0.00 | $0.98 | x |
| 2013-09-30 | $-0.06 | $0.98 | x |
| 2014-09-30 | $-0.10 | $0.98 | x |
| 2015-09-30 | $-0.13 | $0.98 | x |
| 2016-09-30 | $-0.05 | $0.98 | x |
| 2017-09-30 | $-0.94 | $0.98 | x |
| 2018-09-30 | $-9.40 | $0.98 | x |
| 2019-09-30 | $-1.88 | $0.98 | x |
| 2020-09-30 | $2.29 | $0.98 | x |
| 2021-09-30 | $3.68 | $0.98 | x |
| 2022-09-30 | $3.60 | $0.98 | x |
| 2023-09-30 | $2.07 | $0.98 | x |
| 2024-09-30 | $0.18 | $0.98 | x |
| 2025-09-30 | $1.06 | $0.98 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Neuroone Medical Technologies Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -50.98%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -29.80%
- • Asset Turnover: 1.12x
- • Equity Multiplier: 1.53x
- Recent ROE (-50.98%) is above the historical average (-165.96%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 0.00% | -517.91% | 0.13x | 0.00x | $-5.61K |
| 2011 | 0.00% | -511.37% | 0.39x | 0.00x | $-27.28K |
| 2012 | 0.00% | -1515.74% | 0.82x | 0.00x | $-12.24K |
| 2013 | 0.00% | -1515.74% | 0.82x | 0.00x | $-12.24K |
| 2014 | 0.00% | -2446.28% | 2.05x | 0.00x | $-27.72K |
| 2015 | 0.00% | -4688.75% | 3.77x | 0.00x | $-32.71K |
| 2016 | 0.00% | -8472.10% | 0.40x | 0.00x | $-54.71K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-21.15K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.39 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.66 Million |
| 2020 | -660.17% | -708.00% | 0.40x | 2.30x | $-13.85 Million |
| 2021 | -151.79% | -5584.28% | 0.02x | 1.21x | $-10.60 Million |
| 2022 | -104.12% | -5841.95% | 0.01x | 1.34x | $-10.96 Million |
| 2023 | -189.77% | -607.42% | 0.24x | 1.30x | $-12.48 Million |
| 2024 | -1498.53% | -356.74% | 0.64x | 6.53x | $-12.40 Million |
| 2025 | -50.98% | -29.80% | 1.12x | 1.53x | $-4.31 Million |
Industry Comparison
This section compares Neuroone Medical Technologies Corp's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $296,528,539
- Average return on equity (ROE) among peers: -35.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Neuroone Medical Technologies Corp (NMTC) | $5.37 Million | 0.00% | 0.46x | $8.45 Million |
| Abbott Laboratories (ABT) | $2.83 Billion | 34.08% | 0.96x | $190.23 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $2.34 Million |
| Aethlon Medical Inc (AEMD) | $-3.66 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-11.59 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $850.46 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $2.43 Million |
| Allurion Technologies, Inc. (ALUR) | $-77.98 Million | 0.00% | 0.00x | $21.01K |
| Autonomix Medical, Inc. Common Stock (AMIX) | $5.89 Million | -283.55% | 0.29x | $1.61 Million |
| Artivion Inc (AORT) | $276.20 Million | -4.84% | 1.86x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $14.18 Million | 18.92% | 0.18x | $109.52 Million |
About Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson'… Read more